Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving

listen audio

Study Justification:
This study aimed to investigate the associations between maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving. The rationale for this study is that pregnant and post-partum women require increased nutrient intake for optimal cognition, which is important for reasoning and learning in caregiving. Understanding the impact of different nutritional supplements on maternal cognition and caregiving can inform interventions to improve maternal and child health.
Study Highlights:
– The study included 869 pregnant women in Malawi who were randomly assigned to receive either multiple micronutrients (MMN), lipid-based nutrient supplements (LNS), or a control iron/folic acid (IFA) tablet.
– Maternal cognition and caregiving behavior were assessed at 6 months post-partum, along with biomarkers of iron, Vitamin A, B-vitamin, and fatty acid status.
– Among the full group, only one significant difference was found: the IFA arm scored higher than the LNS arm in mental rotation.
– Subgroup analysis showed that women with baseline low hemoglobin, poor iron status, or malaria who received LNS scored higher than the IFA arm in verbal fluency.
– Breastmilk docosahexaenoic acid (DHA) and Vitamin B12 concentrations were positively associated with verbal fluency and digit span forward.
Recommendations:
Based on the findings of this study, the following recommendations can be made:
1. Maternal supplementation with MMN or LNS did not have a positive effect on maternal cognition or caregiving in this population in Malawi.
2. Maternal docosahexaenoic acid (DHA) and Vitamin B12 status may be important for post-partum attention and executive function.
3. Further research is needed to explore the potential benefits of specific nutrients on maternal cognition and caregiving.
Key Role Players:
To address the recommendations, the following key role players may be needed:
– Researchers and scientists to conduct further studies on the impact of specific nutrients on maternal cognition and caregiving.
– Health professionals and policymakers to incorporate the findings into maternal and child health interventions.
– Community health workers to educate pregnant and post-partum women about the importance of adequate nutrition for cognitive function and caregiving.
Cost Items for Planning Recommendations:
While the actual cost of implementing the recommendations will vary depending on the context, some potential cost items to consider in planning include:
– Research funding for further studies on the impact of specific nutrients on maternal cognition and caregiving.
– Training and capacity building for health professionals and community health workers to effectively communicate and implement interventions.
– Development and distribution of educational materials for pregnant and post-partum women on the importance of adequate nutrition for cognitive function and caregiving.

The strength of evidence for this abstract is 6 out of 10.
The evidence in the abstract is rated 6 because it is based on a randomized controlled trial with a large sample size, which provides strong evidence. However, the abstract does not provide detailed information on the statistical methods used, such as the specific analysis models and adjustments for potential confounders. To improve the evidence, the abstract could include more information on the statistical methods used and provide a clear description of the covariates included in the analysis models.

Pregnant and post-partum women require increased nutrient intake and optimal cognition, which depends on adequate nutrition, to enable reasoning and learning for caregiving. We aimed to assess (a) differences in maternal cognition and caregiving between women in Malawi who received different nutritional supplements, (b) 14 effect modifiers, and (c) associations of cognition and caregiving with biomarkers of iron, Vitamin A, B-vitamin, and fatty acid status. In a randomized controlled trial (n = 869), pregnant women daily received either multiple micronutrients (MMN), 20 g/day lipid-based nutrient supplements (LNS), or a control iron/folic acid (IFA) tablet. After delivery, supplementation continued in the MMN and LNS arms, and the IFA control group received placebo until 6 months post-partum, when cognition (n = 712), caregiving behaviour (n = 669), and biomarkers of nutritional status (n = 283) were assessed. In the full group, only one difference was significant: the IFA arm scored 0.22 SD (95% CI [0.01, 0.39], p =.03) higher than the LNS arm in mental rotation. Among subgroups of women with baseline low hemoglobin, poor iron status, or malaria, those who received LNS scored 0.4 to 0.7 SD higher than the IFA arm in verbal fluency. Breastmilk docosahexaenoic acid and Vitamin B12 concentrations were positively associated with verbal fluency and digit span forward (adjusting for covariates ps <.05). In this population in Malawi, maternal supplementation with MMN or LNS did not positively affect maternal cognition or caregiving. Maternal docosahexaenoic acid and B12 status may be important for post-partum attention and executive function.

We conducted an add‐on study of maternal cognition and caregiving in a randomized trial described in more detail by Ashorn et al. (Ashorn et al., 2015), designed to assess the effect of maternal and infant LNS on infant growth. Pregnant women (n = 869) who attended antenatal care at two hospitals and one health center in Mangochi district, Malawi, were enrolled from February 2011 to March 2012 and assigned to one of three intervention arms, described below. Details of randomization and inclusion criteria have been published previously (Ashorn et al., 2015). All participants provided informed consent. Ethical approval for the study procedures was obtained from the Ethics Committees at the University of Malawi College of Medicine and Tampere University Hospital District, Finland. The study was registered with the U.S. National Institutes of Health as a clinical trial (http://www.clinicaltrials.gov; {"type":"clinical-trial","attrs":{"text":"NCT01239693","term_id":"NCT01239693"}}NCT01239693). The sample size of 290 per group, allowing for 20% attrition, provided 83% power to detect a difference of 0.3 SD in continuous scores between groups, with alpha at 0.05 (Zhao & Li, 2012). At enrollment, which occurred at ≤20 weeks gestation, women were randomly assigned to one of three intervention arms; all of whom received two doses of intermittent preventive malaria treatment during pregnancy. The IFA arm received standard antenatal care, including supplementation from enrollment to delivery with one capsule per day containing 60 mg iron and 400 μg folic acid. The IFA arm received a placebo tablet containing 200 mg calcium from delivery to 6 months post‐partum. The MMN arm received one capsule per day from enrollment to 6 months post‐partum that contained a lower dose of iron (20 mg), 400 μg folic acid, and 16 additional micronutrients, shown in Table 1. The LNS arm received daily 20‐g sachets of small quantity LNS produced by Nutriset SAS (Malaunay, France) from enrollment to 6 months post‐partum, containing the same micronutrients as the MMN capsules, four additional minerals, protein, fat, and essential fatty acids (Table 1). Nutrient and energy contents of the dietary supplements Note. IFA = iron/folic acid; MMN = multiple micronutrients; LNS = lipid‐based nutrient supplements. The iron dose was lower for participants in the MMN and LNS arms (20 mg/day) than for those in the IFA arm (60 mg/day), because supplementation with MMN and LNS continued during the first 6 months post‐partum, when the recommended iron intake for lactating women is much lower than the standard antenatal dose (Arimond et al., 2015). On the basis of a literature review and our estimates of the normal dietary iron intakes among pregnant women in the study area, we considered 20 mg/day a safe and adequate dose to prevent iron deficiency anemia during pregnancy, even for women who were iron deficient at enrollment (Arimond et al., 2015). At the time of enrollment, data collectors recorded sociodemographic and maternal anthropometric data. Research nurses assessed the duration of pregnancy with ultrasonography and measured the women's peripheral blood malaria parasitemia and HIV infection with rapid tests. Maternal hemoglobin concentration (Hb; g/dl) was determined using on‐site cuvette readers (HemoCue AB; Angelholm), and zinc protoporphyrin concentration (ZPP; μmol/mol heme) was determined from venous blood samples using a hematofluorometer (Aviv Biomedical Co. NJ, USA), after red blood cells were washed three times with normal saline. Plasma soluble transferrin receptor (sTfR; mg/L) was determined from plasma by immunoturbidimetry on the Cobas Integra 400 system autoanalyzer (F. Hoffmann‐La Roche Ltd, Basel, Switzerland). We determined cut‐off values for low Hb, indicating anemia, and elevated ZPP and sTfR, indicating low iron status, following Adu‐Afarwuah et al. (Adu‐Afarwuah et al., 2016): Hb  70 μmol/mol heme, and sTfR > 6 mg/L. Research staff delivered supplements to participants’ homes every 2 weeks and collected remaining supplements. Adherence was calculated as the percent of delivered supplements that were not returned to research staff. For a detailed description of these variables, see Ashorn et al (Ashorn et al., 2015). Maternal Hb and ZPP were assessed during a clinic visit at 6 months post‐partum in the same way as described above. A subsample of 369 women was randomly selected for assessment of additional biomarkers of nutritional status. Plasma retinol concentration (μmol/L) was assessed by high‐performance liquid chromatography, as previously described (Bieri, Tolliver, & Catignani, 1979). Breastmilk samples were collected at a home visit. Breastmilk DHA (percentage by weight of total fatty acids) was assessed by gas chromatography with flame ionization detection using a GC‐2010 (Shimadzu Corporation, Columbia, MD) equipped with a SP‐2560, 100‐m fused silica capillary column (Supelco, Bellefonte, PA; Oaks et al., 2017). Breastmilk concentrations of Vitamins B1, B2, B3, B6, and B12 were assessed at the Western Human Nutrition Research Center. Free thiamin, thiamin monophosphate, and thiamin triphosphate were measured by high‐performance liquid chromatography‐fluorescence detection after precolumn derivatization to their thiochrome esters (Hampel et al., 2016). Thiamin (B1) was calculated as free thiamin + (thiamin monophosphate × 0.871) + (thiamin pyrophosphate × 0.707). Riboflavin (B2), nicotinamide (B3), pyridoxal (B6), and flavin adenine dinucleotide were measured by UPLC‐MS/MS (Waters, Milford, MA coupled to 4000 QTRAP LC‐MS/MS, AB Sciex, Foster City, CA) as previously described (Hampel, York, & Allen, 2012). Riboflavin was calculated as free riboflavin + (flavin adenine dinucleotide × 0.479). Vitamin B12 was analyzed using an IMMULITE® E‐411 competitive binding assay (Duluth, GA, USA) as previously described (Hampel et al., 2014). For further details, see Supplemental Methods. A team of five project staff, who were blind to intervention arm, visited participants at their homes at 6 months post‐partum to assess maternal cognition and caregiving. If family members or neighbors gathered to observe the assessments, data collectors politely asked them to leave in order to create a private environment, which was generally successful. Apart from the participants, one or more other adults were present at 5% of the visits, and one or more other children were present at 12% of the visits. To assess cognition, we selected three tests that were previously adapted for use in a maternal supplementation trial in Indonesia (Prado et al., 2012). In that study, tests were selected on the basis of the following criteria: widely‐used tests that primarily tap aspects of specific cognitive functions; are tied to particular brain structures and mechanisms; may be affected by micronutrient deficiency based on previous studies; do not require special equipment; do not require literacy; are easily administered and scored; and do not require subjective judgments from the testers. For this study, of the six cognitive tests used by Prado et al. (2012), we selected the three that did not require verbal stimuli to be developed in the local languages: digit span forward and backward, category fluency, and mental rotation. Digit span forward and backward tests measure attention, verbal short‐term memory, and working memory, which are rooted areas in the right dorsolateral prefrontal cortex and bilateral inferior parietal lobule, as well as the anterior cingulate (Gerton et al., 2004). Participants were orally presented with increasingly longer sequences of digits and instructed to either repeat them (digit span forward) or repeat them backwards (digit span backward), until an error was committed on two consecutive trials. The score was the number of sequences correctly repeated. Category fluency assesses semantic memory, which is rooted in areas of the temporal lobe, and executive function, which is rooted in areas of the frontal lobe (Birn et al., 2010). Participants were asked to name as many members of a category as possible in 1 min, first for the category “food” and second for the category “girl’s names.” The score was the average of the two trials. Mental rotation measures visuospatial ability and dynamic mental imagery and activates areas in the superior parietal cortex, inferior prefrontal cortex, and other structures (Zacks, 2008). The participant was visually presented with five rows of figures and instructed to mark the figures that were rotations but not mirror images of the target figure. The score was the percent correct. All cognitive tests were audio recorded and reviewed by a data collector who did not conduct the assessment, to correct any errors. The supervisor reviewed 10% of each batch of submitted forms and recordings. If any error was found, the supervisor reviewed the entire batch and corrected any errors. Thirty‐two participants were tested twice to evaluate test–retest reliability, with a mean test–retest interval of 7 days. Test–retest reliability (Pearson’s r) was 0.62 for digit span forward, 0.50 for digit span backward, 0.66 for category fluency, and 0.63 for mental rotation. We developed a functional health literacy test to assess memory and understanding of health messages communicated in words and pictures, on the basis of a test developed in Ethiopia (Stevenson, 2011). We selected health materials that were common in Malawi and that were relevant for children’s health, such as medication instructions, breastfeeding information, and growth charts. The score was the number of questions answered correctly out of a maximum 36 points. Test–retest reliability was 0.78. Because this test was not audio recorded, we also assessed inter‐rater agreement by periodically assigning pairs of data collectors to visit 32 women. One person conducted the test whereas the other independently completed the form. Inter‐rater agreement was 94%. We assessed maternal caregiving behavior using the Infant/Toddler version of the Home Observation for the Measurement of the Environment (HOME) Inventory (Caldwell & Bradley, 2003). The HOME Inventory measures the amount and quality of stimulation that children receive from their environment. Items assess maternal responsivity, acceptance, and involvement as well as the learning materials, variety, and organization in the child’s environment. To adapt the items to the local context, we conducted a focus group discussion with 12 mothers of young children in each of the three study sites. We used this information to add locally‐appropriate examples, such as toys for making music, and to modify items to increase variance in scores. For example, we changed “At least ten books are visible in the home” to “At least one book is visible in the home.” We eliminated nine items for which we could not find an appropriate modification (e.g., “Child has a special place for toys and treasures”). The adapted tool comprised 18 items coded by observation, 12 by interview, and 6 by observation or interview, according to the standard procedure. The total score was the sum of the item scores, each of which was scored 0 or 1. Inter‐rater agreement was 89% and test–retest reliability was 0.82, using the same procedures described above. The HOME score showed expected correlations with household asset index (r = 0.29, p < .001) and maternal education (r = 0.27, p < .001), providing evidence for convergent validity. All analyses were conducted using SAS Version 9.4 (SAS Institute, Cary, NC). The primary analysis was by intention to treat. We also conducted per protocol analyses excluding women with less than 80% adherence to supplement consumption. For each score, we computed z‐scores on the basis of the distribution of our sample. All cognitive scores were normally distributed, after truncating outliers to the 1st and 99th percentile (2 digit span forward scores, 7 digit span backward scores, and 3 HOME scores). We estimated the difference between the intervention arms first in unadjusted models using analysis of variance and then in adjusted models using analysis of covariance. For each outcome, we determined a set of covariates as any of 17 prespecified covariates that independently predicted that outcome score at p < .1. All potential covariates are listed in Footnote 2 of Table 3. If the F value was significant at p < .05, we used Tukey–Kramer's test to adjust for multiple comparisons for pairwise comparisons between groups. Mean maternal cognitive and HOME z‐scores at the end of the intervention perioda Note. IFA = iron/folic acid; MMN = multiple micronutrients; LNS = lipid‐based nutrient supplements; HOME = home observation for the measurement of the environment. As potential effect modifiers, we examined baseline ZPP and sTfR, plus 12 additional effect modifiers defined a priori: baseline maternal height, BMI, Hb, malaria, education, age, and gestational age; primiparity, season at enrollment, and study site; and household food insecurity access scale score and household asset index. If any interaction between the potential effect modifier and intervention arm was significant at p 1. The first component represented higher nutritional status on all variables, with all eigenvectors >0.3 except breastmilk B1 (0.19), plasma retinol (0.18), and breastmilk DHA (0.05). The second component represented higher breastmilk B1, B2, and B6, but lower Hb, iron, and Vitamin A status. The third component represented higher breastmilk DHA (eigenvector = 0.51) and Vitamin B12 (eigenvector = 0.59). For details, see Table S1. For each maternal cognitive and caregiving score, we examined the association with each of the three nutritional biomarker components, adjusting for the same set of covariates specific to that outcome.

Based on the provided description, here are some potential innovations that could be used to improve access to maternal health:

1. Mobile Health (mHealth) Applications: Develop mobile applications that provide pregnant and post-partum women with access to information and resources related to maternal nutrition, cognition, and caregiving. These apps can provide personalized recommendations, reminders for supplement intake, and educational materials.

2. Telemedicine: Implement telemedicine services to enable remote consultations between pregnant women and healthcare providers. This can help overcome geographical barriers and provide access to expert advice and guidance on maternal health.

3. Community Health Workers: Train and deploy community health workers who can provide education and support to pregnant and post-partum women in remote areas. These workers can conduct home visits, deliver supplements, and provide guidance on nutrition and caregiving practices.

4. Nutritional Supplements: Develop innovative nutritional supplements that are specifically tailored to meet the needs of pregnant and post-partum women. These supplements can be fortified with essential nutrients such as iron, Vitamin A, B-vitamins, and fatty acids to support maternal cognition and caregiving.

5. Health Literacy Programs: Implement health literacy programs that focus on improving maternal health knowledge and understanding among pregnant and post-partum women. These programs can include interactive workshops, educational materials, and community-based initiatives.

6. Public-Private Partnerships: Foster collaborations between government agencies, healthcare providers, and private companies to improve access to maternal health services. This can involve leveraging existing infrastructure, resources, and expertise to reach more women in need.

7. Data Analytics: Utilize data analytics and machine learning algorithms to identify patterns and trends in maternal health outcomes. This can help identify high-risk populations, optimize resource allocation, and inform targeted interventions.

8. Behavior Change Interventions: Develop behavior change interventions that promote healthy nutrition and caregiving practices among pregnant and post-partum women. These interventions can utilize techniques such as motivational interviewing, goal setting, and social support to facilitate positive behavior change.

9. Maternal Health Education Campaigns: Launch public awareness campaigns that focus on raising awareness about the importance of maternal nutrition, cognition, and caregiving. These campaigns can utilize various media channels, including television, radio, social media, and community events.

10. Integration of Services: Integrate maternal health services with existing healthcare systems, such as antenatal care and postnatal care. This can ensure a continuum of care and facilitate access to comprehensive maternal health services.

It is important to note that the implementation of these innovations should be context-specific and tailored to the needs and resources of the target population.
AI Innovations Description
The study described in the provided text aimed to assess the associations between maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving, specifically focusing on the impact of different nutritional supplements on these outcomes. The study was conducted in Malawi and involved a randomized controlled trial with 869 pregnant women.

The participants were divided into three intervention arms: the first group received multiple micronutrients (MMN), the second group received lipid-based nutrient supplements (LNS), and the third group received a control iron/folic acid (IFA) tablet. The supplementation continued after delivery for the MMN and LNS groups, while the IFA group received a placebo until 6 months post-partum.

The researchers assessed cognition, caregiving behavior, and biomarkers of nutritional status at 6 months post-partum. The cognitive tests included digit span forward and backward, category fluency, and mental rotation. Maternal caregiving behavior was measured using the Infant/Toddler version of the Home Observation for the Measurement of the Environment (HOME) Inventory.

The results of the study showed that there was only one significant difference between the intervention arms in terms of cognition, with the IFA arm scoring higher than the LNS arm in mental rotation. However, among subgroups of women with baseline low hemoglobin, poor iron status, or malaria, those who received LNS scored higher than the IFA arm in verbal fluency.

The study also found positive associations between maternal biomarkers of nutritional status, such as breastmilk docosahexaenoic acid (DHA) and Vitamin B12 concentrations, with verbal fluency and digit span forward.

In conclusion, the study did not find a significant positive effect of maternal supplementation with MMN or LNS on maternal cognition or caregiving behavior. However, it highlighted the potential importance of maternal DHA and B12 status for post-partum attention and executive function.

Based on these findings, a recommendation to improve access to maternal health could be to prioritize interventions that focus on improving maternal nutrition, particularly in terms of DHA and B12 status. This could involve providing nutritional supplements or promoting a diet rich in these nutrients during pregnancy and post-partum. Additionally, efforts should be made to identify and target subgroups of women with low hemoglobin, poor iron status, or malaria, as they may benefit more from specific interventions, such as LNS supplementation, to improve cognitive outcomes.
AI Innovations Methodology
Based on the provided description, here are some potential recommendations for improving access to maternal health:

1. Increase availability and accessibility of nutritional supplements: Ensure that pregnant and post-partum women have easy access to multiple micronutrients (MMN), lipid-based nutrient supplements (LNS), and iron/folic acid (IFA) tablets. This can be done by distributing these supplements through healthcare facilities, community health workers, or mobile clinics.

2. Improve education and awareness: Implement educational programs to raise awareness about the importance of maternal nutrition during pregnancy and post-partum. This can include providing information on the benefits of specific nutrients, proper supplementation, and healthy eating habits.

3. Strengthen antenatal care services: Enhance antenatal care services by integrating nutritional counseling and supplementation into routine visits. This can involve training healthcare providers to provide accurate and up-to-date information on maternal nutrition and offering regular monitoring of nutritional status.

4. Address barriers to adherence: Identify and address barriers that may prevent pregnant and post-partum women from adhering to nutritional supplementation. This can include addressing cultural beliefs, financial constraints, and logistical challenges.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define the target population: Determine the specific population that will be the focus of the simulation, such as pregnant and post-partum women in a particular region or country.

2. Collect baseline data: Gather data on the current state of access to maternal health, including nutritional supplementation rates, healthcare utilization, and maternal health outcomes. This can be done through surveys, interviews, or existing data sources.

3. Develop a simulation model: Create a mathematical or computational model that represents the target population and simulates the impact of the recommendations. The model should consider factors such as population size, demographic characteristics, healthcare infrastructure, and resource availability.

4. Incorporate intervention scenarios: Introduce the recommended interventions into the simulation model and assess their potential impact on access to maternal health. This can involve adjusting parameters related to nutritional supplementation coverage, education and awareness programs, antenatal care services, and barriers to adherence.

5. Run simulations and analyze results: Run multiple simulations using different intervention scenarios and analyze the outcomes. This can include measuring changes in nutritional supplementation rates, healthcare utilization, and maternal health outcomes. Compare the results of different scenarios to identify the most effective interventions.

6. Validate the model: Validate the simulation model by comparing the simulated outcomes with real-world data. This can help ensure that the model accurately represents the target population and provides reliable predictions.

7. Refine and iterate: Based on the simulation results and validation, refine the model and interventions as needed. Iterate the simulation process to further optimize the recommendations and improve access to maternal health.

It is important to note that the methodology described above is a general framework and may need to be adapted based on the specific context and data availability.

Partagez ceci :
Facebook
Twitter
LinkedIn
WhatsApp
Email